These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15564232)

  • 61. Recurrent small intestinal ileus secondary to valsartan treatment.
    Saadi T; Brun R; Chowers Y; Baruch Y; Waterman M
    J Clin Gastroenterol; 2014; 48(5):462-3. PubMed ID: 24296424
    [No Abstract]   [Full Text] [Related]  

  • 62. Noncholestatic acute hepatocellular injury following candesartan administration.
    Lammel-Lindemann JA; Flores-Villalba E; Martagón AJ; DeObeso-Gonzalez E; Puente-Gallegos F
    Br J Clin Pharmacol; 2018 Jan; 84(1):204-207. PubMed ID: 28841231
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential effects of angiotensin II receptor blockers on Aβ generation.
    Liu J; Liu S; Tanabe C; Maeda T; Zou K; Komano H
    Neurosci Lett; 2014 May; 567():51-6. PubMed ID: 24680748
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [In diarrhea of unknown origin also think of olmesartan!].
    Storr M
    MMW Fortschr Med; 2015 Mar; 157(4):34. PubMed ID: 25743974
    [No Abstract]   [Full Text] [Related]  

  • 65. Rash and acute nephritic syndrome due to candesartan.
    Morton A; Muir J; Lim D
    BMJ; 2004 Jan; 328(7430):25. PubMed ID: 14703542
    [No Abstract]   [Full Text] [Related]  

  • 66. Pemphigus foliaceus induced by an angiotensin II receptor blocker.
    Bae YI; Yun SJ; Lee SC; Park GT; Lee JB
    Clin Exp Dermatol; 2008 Nov; 33(6):721-3. PubMed ID: 18627397
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Preferences in general practice. Interview by Christine Vetter].
    Holzgreve H
    Fortschr Med; 1998 May; 116(13):44-5. PubMed ID: 9630784
    [No Abstract]   [Full Text] [Related]  

  • 68. Angioedema due to valsartan.
    Martínez Alonso JC; Domínguez Ortega FJ; Méndez Alcalde J; Fuentes Gonzalo MJ
    Allergy; 2003 Apr; 58(4):367. PubMed ID: 12708991
    [No Abstract]   [Full Text] [Related]  

  • 69. Fetal toxicity of valsartan and possible reversible adverse side effects.
    Berkane N; Carlier P; Verstraete L; Mathieu E; Heim N; Uzan S
    Birth Defects Res A Clin Mol Teratol; 2004 Aug; 70(8):547-9. PubMed ID: 15329835
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New Onset Villous Atrophy in a Patient With Celiac Disease.
    Cartee AK; Reyes Genere JP; Oxentenko AS
    Gastroenterology; 2018 Oct; 155(4):988-989. PubMed ID: 30025705
    [No Abstract]   [Full Text] [Related]  

  • 71. Olmesartan-associated sprue-like enteropathy.
    Stanich PP; Yearsley M; Meyer MM
    J Clin Gastroenterol; 2013; 47(10):894-5. PubMed ID: 23751857
    [No Abstract]   [Full Text] [Related]  

  • 72. Drug-induced isolated visceral angioneurotic edema.
    Arakawa M; Murata Y; Rikimaru Y; Sasaki Y
    Intern Med; 2005 Sep; 44(9):975-8. PubMed ID: 16258215
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Sleep apnea: RR lowering drugs need to be administered in the evening].
    Zidek W
    MMW Fortschr Med; 2015 Mar; 157 Suppl 1():31. PubMed ID: 26012982
    [No Abstract]   [Full Text] [Related]  

  • 74. Olmesartan: sprue-like enteropathy.
    Prescrire Int; 2014 Apr; 23(148):102. PubMed ID: 24860900
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Acute hepatitis induced by valsartan].
    Reñé JM; Buenestado J; Sesé E; Miñana JM
    Med Clin (Barc); 2001 Nov; 117(16):637-8. PubMed ID: 11714476
    [No Abstract]   [Full Text] [Related]  

  • 76. Defective embryogenesis with angiotensin II receptor antagonists in pregnancy.
    Cox RM; Anderson JM; Cox P
    BJOG; 2003 Nov; 110(11):1038. PubMed ID: 14592593
    [No Abstract]   [Full Text] [Related]  

  • 77. Linear IgA bullous dermatosis induced by angiotensin receptor antagonists.
    Peña-Penabad C; Rodríguez-Lozano J; del Pozo J; García-Silva J; Fonseca E
    Am J Med; 2003 Feb; 114(2):163-4. PubMed ID: 12586244
    [No Abstract]   [Full Text] [Related]  

  • 78. [Fetal toxicity of angiotensin-II receptor antagonists].
    Payen V; Chemin A; Jonville-Béra AP; Saliba E; Cantagrel S
    J Gynecol Obstet Biol Reprod (Paris); 2006 Nov; 35(7):729-31. PubMed ID: 17088776
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Candesartan-induced cholestatic hepatitis: a case report].
    Jiménez-Sáenz M; Arroyo Q; Sanjuan M; Herrerías JM
    Gastroenterol Hepatol; 2010 Jan; 33(1):66-7. PubMed ID: 19713003
    [No Abstract]   [Full Text] [Related]  

  • 80. Lithium intoxication after administration of AT1 blockers.
    Zwanzger P; Marcuse A; Boerner RJ; Walther A; Rupprecht R
    J Clin Psychiatry; 2001 Mar; 62(3):208-9. PubMed ID: 11305712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.